Literature DB >> 17133402

'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation.

Ingo Vernaleken1, Hans-Georg Buchholz, Yoshitaka Kumakura, Thomas Siessmeier, Peter Stoeter, Peter Bartenstein, Paul Cumming, Gerhard Gründer.   

Abstract

Dopamine neurotransmission influences those cognitive processes, which are generally regarded as prefrontal cortical functions. In previous positron-emission-tomography (PET) studies, net blood-brain clearance of [18F]-fluoro-l-DOPA (FDOPA) correlated with impaired cognitive performance in patients with Parkinson's disease or schizophrenia. We hypothesized that FDOPA influx also correlates with performance of cognitive tasks associated with prefrontal functioning in healthy volunteers. The net blood-brain clearance of FDOPA (K(in)(app)) was mapped in a group of 11 healthy volunteers and calculated in striatal volumes-of-interest. The Wisconsin-Card-Sorting-Test (WCST), Stroop-Test, Trail-Making-Test (TMT-A/B), and Continuous-Performance-Test (CPT-M) had been administered previously to the same subjects. No correlation of K(in) (app) with perseverative errors in WCST or age could be found. However, there were significant positive correlations between the magnitude of K(in)(app) in caudate nucleus, putamen, and midbrain with performance of the TMT-B, CPT-M, and the Stroop test. Highest correlations were found between the time needed to perform the Stroop interference task and the K(in)(app) of striatal areas (Caudate nucleus: -0.780, P = 0.005; putamen: -0.870, P < 0. 001). Thus, the present findings reveal a strong correlation between dopamine synthesis capacity in striatum of healthy volunteers and performance of cognitive tasks linked to the prefrontal cortex. Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17133402      PMCID: PMC6871482          DOI: 10.1002/hbm.20325

Source DB:  PubMed          Journal:  Hum Brain Mapp        ISSN: 1065-9471            Impact factor:   5.038


  44 in total

1.  A continuous performance test of brain damage.

Authors:  L H BECK; E D BRANSOME; A F MIRSKY; H E ROSVOLD; I SARASON
Journal:  J Consult Psychol       Date:  1956-10

2.  Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge.

Authors:  Ingo Vernaleken; Yoshitaka Kumakura; Paul Cumming; Hans-Georg Buchholz; Thomas Siessmeier; Peter Stoeter; Matthias J Müller; Peter Bartenstein; Gerhard Gründer
Journal:  Neuroimage       Date:  2006-01-24       Impact factor: 6.556

3.  The performance of young schizophrenics and young normals on the Wisconsin Card Sorting Test.

Authors:  E T FEY
Journal:  J Consult Psychol       Date:  1951-08

4.  Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals.

Authors:  N D Volkow; R C Gur; G J Wang; J S Fowler; P J Moberg; Y S Ding; R Hitzemann; G Smith; J Logan
Journal:  Am J Psychiatry       Date:  1998-03       Impact factor: 18.112

5.  Memory and executive function in sporadic and familial Parkinson's disease.

Authors:  K Dujardin; L Defebvre; C Grunberg; E Becquet; A Destée
Journal:  Brain       Date:  2001-02       Impact factor: 13.501

6.  Evidence of difficulties in sustained attention in children with ADDH.

Authors:  W T Seidel; M Joschko
Journal:  J Abnorm Child Psychol       Date:  1990-04

7.  Dopamine D2 receptors in the insular cortex and the personality trait of novelty seeking.

Authors:  T Suhara; F Yasuno; Y Sudo; M Yamamoto; M Inoue; Y Okubo; K Suzuki
Journal:  Neuroimage       Date:  2001-05       Impact factor: 6.556

8.  Stimulated limbic and striatal dopamine release measured by fast cyclic voltammetry: anatomical, electrochemical and pharmacological characterisation.

Authors:  J A Stamford; Z L Kruk; J Millar
Journal:  Brain Res       Date:  1988-06-28       Impact factor: 3.252

9.  Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

Authors:  J Hietala; E Syvälahti; K Vuorio; V Räkköläinen; J Bergman; M Haaparanta; O Solin; M Kuoppamäki; O Kirvelä; U Ruotsalainen
Journal:  Lancet       Date:  1995-10-28       Impact factor: 79.321

10.  6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine.

Authors:  A C Roberts; M A De Salvia; L S Wilkinson; P Collins; J L Muir; B J Everitt; T W Robbins
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

View more
  25 in total

1.  Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies.

Authors:  Paolo Fusar-Poli; Andreas Meyer-Lindenberg
Journal:  Schizophr Bull       Date:  2012-01-26       Impact factor: 9.306

2.  Tackling frontal lobe-related functions in PKU through functional brain imaging: a Stroop task in adult patients.

Authors:  Benedikt Sundermann; Bettina Pfleiderer; Harald E Möller; Wolfram Schwindt; Josef Weglage; Jöran Lepsien; Reinhold Feldmann
Journal:  J Inherit Metab Dis       Date:  2011-04-14       Impact factor: 4.982

3.  Ventral striatal dopamine reflects behavioral and neural signatures of model-based control during sequential decision making.

Authors:  Lorenz Deserno; Quentin J M Huys; Rebecca Boehme; Ralph Buchert; Hans-Jochen Heinze; Anthony A Grace; Raymond J Dolan; Andreas Heinz; Florian Schlagenhauf
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-20       Impact factor: 11.205

4.  Cognitive control network dysconnectivity and response to antipsychotic treatment in schizophrenia.

Authors:  Elyse J Cadena; David M White; Nina V Kraguljac; Meredith A Reid; Ripu Jindal; Roland Matthew Pixley; Adrienne C Lahti
Journal:  Schizophr Res       Date:  2018-08-08       Impact factor: 4.939

Review 5.  Imaging addiction: D2 receptors and dopamine signaling in the striatum as biomarkers for impulsivity.

Authors:  Pierre Trifilieff; Diana Martinez
Journal:  Neuropharmacology       Date:  2013-07-10       Impact factor: 5.250

6.  Decline in prefrontal catecholamine synthesis explains age-related changes in cognitive speed beyond regional grey matter atrophy.

Authors:  Jan Kalbitzer; Lorenz Deserno; Florian Schlagenhauf; Anne Beck; Thomas Mell; Gerd Bahr; Hans-Georg Buchholz; Michail Plotkin; Ralph Buchert; Yoshitaka Kumakura; Paul Cumming; Andreas Heinz; Michael A Rapp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-19       Impact factor: 9.236

7.  A cognitive neuroscience-based computerized battery for efficient measurement of individual differences: standardization and initial construct validation.

Authors:  Ruben C Gur; Jan Richard; Paul Hughett; Monica E Calkins; Larry Macy; Warren B Bilker; Colleen Brensinger; Raquel E Gur
Journal:  J Neurosci Methods       Date:  2009-11-27       Impact factor: 2.390

Review 8.  Executive function, neural circuitry, and genetic mechanisms in schizophrenia.

Authors:  Daniel Paul Eisenberg; Karen Faith Berman
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

Review 9.  Pathway-Specific Dopamine Abnormalities in Schizophrenia.

Authors:  Jodi J Weinstein; Muhammad O Chohan; Mark Slifstein; Lawrence S Kegeles; Holly Moore; Anissa Abi-Dargham
Journal:  Biol Psychiatry       Date:  2016-03-31       Impact factor: 13.382

10.  Relationship of striatal dopamine synthesis capacity to age and cognition.

Authors:  Meredith N Braskie; Claire E Wilcox; Susan M Landau; James P O'Neil; Suzanne L Baker; Cindee M Madison; Jennifer T Kluth; William J Jagust
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.